Akiko Koakutsu

Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist

Yasuharu Kimura, Ken-ichi Hatanaka, Yuki Naitou et al. · European Journal of Pharmacology · 2003 · 52 citations · Full text

Biochemistry, Functional Selectivity, Medicine +5

Effects of selective endothelin ET A receptor antagonists on endothelin-1-induced potentiation of cancer pain

Hironori Yuyama, Akiko Koakutsu, Noriko Fujiyasu et al. · European Journal of Pharmacology · 2004 · 39 citations

Molecular Pharmacology, Health Sciences, Pain Medicine +9

Inhibitory Effects of a Selective Endothelin-A Receptor Antagonist YM598 on Endothelin-1-induced Potentiation of Nociception in Formalin-induced and Prostate Cancer-induced Pain Models in Mice

Hironori Yuyama, Akiko Koakutsu, Noriko Fujiyasu et al. · Journal of Cardiovascular Pharmacology · 2004 · 28 citations

Pain Medicine, Neuropathic Pain, Molecular Pain +18

Chronic treatment with olanzapine via a novel infusion pump induces adiposity in male rats

Miwako Shobo, Hiroshi Yamada, Akiko Koakutsu et al. · Life Sciences · 2011 · 21 citations

Obesity, Metabolic Syndrome, Energy Homeostasis +9

The orally active nonpeptide selective endothelin ETA receptor antagonist YM598 prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats

Hironori Yuyama, Akira Fujimori, Masanao Sanagi et al. · European Journal of Pharmacology · 2004 · 20 citations

Hypertension, Pulmonary Arterial Hypertension, Pulmonary Circulation +9